IL6 and metabolic dysfunction-associated steatotic liver disease: Moreover, in addition to the known metabolic correlates, the possible molecular mediators linking NAFLD with DPN could include the increased release of some pathogenic mediators from the liver, such as advanced glycation end-products, reactive oxygen species, C reactive protein, IL-6, and TNF-α, as also suggested for retinopathy and chronic kidney disease [49].